IP Library Patent Application 10945593
Patent Application
App. No. 10/945,593

Methods of device-assisted drug delivery

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/945,593
Abstract

This invention describes the simultaneous or sequential administration of therapeutic or diagnostic agents using different devices in combination with a chemical formulation that incorporates or uses vasomodulatory chemical agents as part of the drug delivery vehicle. Methods include the addition of various vasodilatory and vasoconstrictive agents to enhance the systemic or localized tissue delivery of therapeutic or diagnostic agents delivered into a body through the use of an apparatus or device.

Claims (9)

1 . In a method of delivering of an active ingredient into the skin with a device that penetrates the stratum corneum layer but not the subcutaneous layer, the step of enhancing the delivery of said active ingredient through said subcutaneous layer by applying to the site of delivery a vasodilator.

2 . The method of claim 1 , wherein said vasodilator is applied prior to delivering said active ingredient.

3 . The method of claim 1 , wherein said vasodilator is applied simultaneously with the delivery of said active ingredient.

4 . The method of claim 1 , wherein said vasodilator is applied after the delivery of said active ingredient.

5 . The method of claim 1 , wherein said active ingredient is delivered with a microneedle.

6 . The method of claim 1 , wherein said active ingredient is delivered with a syringe and needle.

7 . The method of claim 1 , further comprising applying to said site of delivery a penetration enhancing agent.

8 . The method of claim 7 , wherein said penetration enhancing agent is selected from the group consisting of liposomes, lipid based emulsions and lipid associated hydro-gels.

9 . The method of claim 1 , wherein said vasodilator is added to a formulation comprising said active ingredient.

Assignments (2)
SECURITY INTEREST Recorded Jun 5, 2014
From: BIOCHEMICS, INC.
To: BIO STRATEGIES, LP
Reel/Frame 033086/0888 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2004
From: CARTER, STEPHEN G.; ZHU, ZHEN; PATEL, KANU
To: BIOCHEMICS, INC.
Reel/Frame 016095/0035 →